Expression of Serum Vascular Endothelial Growth Factor and Angiopoietin Receptor Tie-2 in Essential Hypertension

Creative Commons License

FİLİZ A. K., ÖZDEMİR E., GÜNEŞ H., YILMAZ M.

WEST INDIAN MEDICAL JOURNAL, cilt.69, sa.7, ss.464-470, 2022 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 69 Sayı: 7
  • Basım Tarihi: 2022
  • Doi Numarası: 10.7727/wimj.2015.357
  • Dergi Adı: WEST INDIAN MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Veterinary Science Database
  • Sayfa Sayıları: ss.464-470
  • Anahtar Kelimeler: Angiopoietin receptor, endothelial disfunction, hypertension, Tie-2 receptor, vascular endothelial growth factor, TARGET ORGAN DAMAGE, BLOOD-PRESSURE, ANGIOGENESIS, TRIAL, BEVACIZUMAB, VEGF, THROMBOGENESIS, ANTIBODY, DISEASE, CELLS
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Objective: To investigate the serum levels of a vascular endothelial growth factor (VEGF), an angiogenic factor and a soluble angiopoietin receptor Tie-2 (sTie-2) in patients with essential hypertension.